Orthofix Medical Inc. (OFIX)

Market Cap	472.50M -28.4%
Revenue (ttm)	822.31M +2.9%
Net Income	-92.19M
EPS	-2.33
Shares Out	40.14M
PE Ratio	n/a
Forward PE	13.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	229,891
Open	11.47
Previous Close	11.53
Day's Range	11.37 - 11.82
52-Week Range	10.24 - 16.99
Beta	0.82
Analysts	Buy
Price Target	17.25 (+46.56%)
Earnings Date	May 5, 2026

About OFIX

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graf...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 1,605
• Stock Exchange: NASDAQ
• Ticker Symbol: OFIX
• Website: https://orthofix.com

Financial Performance

In 2025, Orthofix Medical's revenue was $822.31 million, an increase of 2.85% compared to the previous year's $799.49 million. Losses were -$92.19 million, -26.83% less than in 2024.

Analyst Summary

According to 5 analysts, the average rating for OFIX stock is "Buy." The 12-month stock price target is $17.25, which is an increase of 46.56% from the latest price.

Price Target

$17.25

(46.56% upside)

Analyst Consensus: Buy